Kowa Company, Ltd.

This study tested a once-daily extended-release tablet called K-877 in 121 adults with high triglycerides (a type of blood fat). Participants took the pill for 52 weeks, starting at 0.2 mg and increasing to 0.4 mg if needed. The goal was to see if the drug safely lowers triglycer…

This study tested a drug called pemafibrate (K-877) in 71 adults with high cholesterol who cannot take statins because of side effects. Participants took either a low or high dose of pemafibrate or a placebo for 12 weeks. The main goal was to see if the drug safely lowers LDL (ba…

This study tested a new controlled-release version of the drug pemafibrate in 60 adults with dyslipidemia (abnormal fat levels in the blood). The goal was to see if the new tablet works better or more safely than the current version at lowering triglycerides. Participants took bo…